Asker Healthcare Group ABOSTO:ASKER +1.13%13 EV-to-FCF is 36.98 as of Jul. 03, 2026, which is 24% below its 10-year median of 48.65. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 75 Medical Distribution companies, Asker Healthcare Group AB ranks worse than 69.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Asker Healthcare Group AB's Enterprise Value is kr37,650 Mil.
Asker Healthcare Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr1,018 Mil. Therefore, Asker Healthcare Group AB's EV-to-FCF for today is 36.98.
The historical rank and industry rank for Asker Healthcare Group AB's EV-to-FCF or its related term are showing as below:
OSTO:ASKER'
s EV-to-FCF Range Over the Past 10 Years
Min: 30.72 Med: 48.65 Max: 89.65
Current: 32.68
During the past 4 years, the highest EV-to-FCF of Asker Healthcare Group AB was 89.65. The lowest was 30.72. And the median was 48.65.
OSTO:ASKER's EV-to-FCF is ranked worse than 69.33% of 75
companies
in the Medical Distribution industry
Industry Median: 16.66
vs OSTO:ASKER: 32.68
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Asker Healthcare Group AB (OSTO:ASKER) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Asker Healthcare Group AB's PE Ratio (TTM) for today is calculated as:
Asker Healthcare Group AB's share price for today is kr84.95.
Asker Healthcare Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.550.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Asker Healthcare Group AB EV-to-FCF Related Terms
Asker Healthcare Group AB EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Asker Healthcare Group AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's EV-to-FCF falls into.
Asker Healthcare Group AB's current Enterprise Value is kr37,650 Mil.
Asker Healthcare Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,018 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asker Healthcare Group AB (OSTO:ASKER) has a EV-to-FCF of 36.98 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Asker Healthcare Group AB and its competitors. This is 24% below median its historical median of 48.65. Over the past decade, Asker Healthcare Group AB's EV-to-FCF has ranged from 30.72 to 89.65. According to the industry distribution chart, Asker Healthcare Group AB ranks #52 out of 75 companies in the Medical Distribution industry, placing it in the top 69.3%.
Is Asker Healthcare Group AB's EV-to-FCF too high?
Asker Healthcare Group AB's current EV-to-FCF of 36.98 is 24% below median its 10-year median of 48.65. Over the past 10 years, this metric has ranged from a low of 30.72 to a high of 89.65. The Medical Distribution industry median EV-to-FCF is 16.66. Asker Healthcare Group AB's value of 36.98 is 122% above this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #52 out of 75 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #52 out of 75 companies for EV-to-FCF. This places Asker Healthcare Group AB in the lower half of its industry. The industry median EV-to-FCF is 16.66. Asker Healthcare Group AB's value of 36.98 is 122% above this benchmark. Historically, Asker Healthcare Group AB's own EV-to-FCF has ranged from 30.72 to 89.65 over the past decade. While the company's 10-year median is 48.65 vs. the industry median of 16.66, Asker Healthcare Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.66, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current EV-to-FCF of 36.98 is 122% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current EV-to-FCF is 36.98, which is 24% below median its own 10-year median of 48.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current EV-to-FCF of 36.98. The current EV-to-FCF is 36.98, which is 24% below median its 10-year median of 48.65 and 122% above the Medical Distribution industry median of 16.66. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current EV-to-FCF is 36.98 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
